Career Enhancement Program

职业提升计划

• 批准号: 10708861
• 负责人: Payal Kapur
• 金额: $ 8.82万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-01 至 2027-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10708861
• 关键词: Address; Award; Budgets; Cells; Cellular biology; Clinical; Clinical Investigator; Complement; Comprehensive Cancer Center; Core Facility; Data; Development; Development Plans; Direct Costs; Early Diagnosis; Education; Educational workshop; Electronic Mail; Extramural Activities; Faculty; Female; Foundations; Funding; Funding Agency; Genitourinary system; Goals; Grant; Institution; International; Kidney; Leadership; Manuscripts; Medical center; Mentors; Mentorship; Minority Groups; Mission; Molecular; Pathologist; Pathology; Preparation; Prevention; Publications; Qualifying; Renal carcinoma; Reproduction spores; Research; Research Personnel; Scientist; Seasons; Selection Criteria; Talents; Texas; Training; Underrepresented Minority; United States National Institutes of Health; Universities; Woman; Work; anticancer research; career; career development; design; experience; innovation; interest; meetings; member; mid-career faculty; minority scientist; next generation; novel; outreach; professor; programs; recruit; research study; role model; skills; success; symposium; synergism; translational cancer research; translational potential

Project Summary The CEP provides seed funding for early-stage investigators whose research addresses important objectives in kidney cancer. The goal of the CEP is to attract talented, typically early-career, investigators with novel ideas and/or experimental approaches in translational kidney cancer research. The CEP is led by an energetic leadership team who represent the spectrum of academic experience, have complementary research expertise, and offer diverse perspectives. They include a clinical pathologist, Dr. Kapur, Professor of Pathology and Director of Genitourinary Pathology; a molecular biologist, Dr. Zhang, Associate Professor of Pathology; and a cell biologist, Dr. Conacci-Sorrell, Assistant Professor of Cell Biology. Dr. Conacci-Sorrell, a previous CEP recipient, is a member of an underrepresented minority (URM) group and a role model. The CEP is committed to recruiting and training the next generation of researchers who are focused on translational kidney cancer research, with an emphasis on attracting women and URMs. The CEP partners with the Office of Faculty Diversity and Development and the Office of Women’s Careers to recruit women and URM faculty. CEP proposals are solicited by Core A via campus-wide email. Submitted proposals are reviewed by at least 4 reviewers, including members of the SPORE leadership, IAB/EAB, and other UTSW faculty with relevant expertise. Criteria for selection include significance, innovation, approach, investigator qualifications (and mentorship), and translational potential. The highest-scoring proposals are funded following approval by the SPORE Executive Committee. The CEP will assist awardees by: (a) providing preferential access to all SPORE Cores, (b) assigning mentors, (c) formulating a career development plan that includes relevant career development workshops, seminars, and educational courses, (d) assisting in identifying other funding sources and putting together competitive applications, and (e) providing forums for brainstorming and synergy. Metrics of success include presentations at scientific meetings, successful competition for independent grant support, publication of original research studies, and promotion through the academic ranks. Enabling an expansion of the CEP/DRP, SPORE funding is complemented by funds from the Simmons Comprehensive Cancer Center (SCCC) and UTSW, which provide $400,000/year in direct costs. The CEP plans to award 3 to 6 projects per year. The CEP will accomplish its mission through the following Aims. Aim 1. Promoting translational kidney cancer research by recruiting and supporting junior faculty. Aim 2. Attracting seasoned investigators to refocus their expertise on kidney cancer. Aim 3. Promoting diversity by recruiting women and underrepresented minorities. Aim 4. Mentoring new investigators in the kidney cancer field through traditional and innovative mechanisms. Illustrating our commitment to supporting an exceptional CEP and highlighting our successful outreach efforts, 19 CEP awards were funded, including 7 women and 3 underrepresented minorities during the first 5 years.

项目摘要 CEP为早期研究人员提供种子资金，他们的研究涉及以下重要目标： 肾癌CEP的目标是吸引有才华的，通常是职业生涯早期的，具有新颖想法的调查人员 和/或转化肾癌研究中的实验方法。CEP由一位精力充沛的 领导团队谁代表学术经验的频谱，有互补的研究专长， 并提供不同的视角。他们包括临床病理学家，Kapur博士，病理学教授和主任 泌尿生殖道病理学;分子生物学家，张博士，病理学副教授;和细胞 生物学家，Conacci-Sorrell博士，细胞生物学助理教授。科纳奇-索雷尔博士，以前的CEP接受者， 是代表性不足的少数群体（URM）的成员和榜样。CEP致力于招募 培养下一代专注于转化型肾癌研究的研究人员， 强调吸引妇女和统一登记机制。CEP与教师多样性办公室合作， 发展和妇女职业办公室招聘妇女和城市资源管理学院教师。CEP提案征集 通过校园范围内的电子邮件发送给核心A。提交的提案由至少4名审查员审查，包括委员 SPORE领导层，IAB/EAB和其他具有相关专业知识的UTSW教师。甄选标准包括 重要性、创新性、方法、研究者资格（和指导）和翻译潜力。的 得分最高的提案在获得SPORE执行委员会批准后获得资助。卓越医療中心将 协助获奖者：（a）提供优先访问所有SPORE核心，（B）分配导师，（c）制定 职业发展计划，包括相关的职业发展讲习班，研讨会和教育 课程，（d）协助确定其他资金来源，并提出竞争性申请，以及（e） 提供集思广益和协同作用的论坛。成功的例子包括在科学会议上的演讲， 成功竞争独立赠款支持、发表原创研究报告和推广 通过学术排名。为了扩大CEP/DRP，SPORE资金得到了资金的补充 西蒙斯综合癌症中心（SCCC）和UTSW，每年直接提供40万美元 成本CEP计划每年授予3至6个项目。CEP将通过以下方式完成其使命 目标。目标1.通过招募和支持初级教师促进转化肾癌研究。目标2. 吸引经验丰富的研究人员重新关注他们对肾癌的专业知识。目标3。促进多样性， 招募妇女和代表性不足的少数民族。目标4。指导新的肾癌研究者 通过传统和创新机制。说明我们致力于支持一个特殊的 为了突出我们成功的外联工作，为19个CEP奖提供了资金，其中包括7名妇女和3名 在头五年里，少数民族的代表人数不足。